Inventor · disambiguated record
Jaime Escobedo
Also filed as: ESCOBEDO JAIME · ESCOBEDO JAIME A
26 granted patents·23 pending applications·969 citations·filing 1993–2022
97Inventor score
Files withCHIRON CORP10UNIV CALIFORNIA9NOVARTIS VACCINES & DIAGNOSTIC4FORMA THERAPEUTICS INC3RIBOZYME PHARM INC3
Top patents by PatentIndex Score
49 records- 0196US6566127B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1999·Granted May 20, 2003·141 cites·5 claims
- 0296US6346398B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1996·Granted Feb 12, 2002·245 cites·23 claims
- 0395US7776523B2Endogenous retroviruses up-regulated in prostate cancerNOVARTIS VACCINES & DIAGNOSTIC·Filed 2001·Granted Aug 17, 2010·79 cites·7 claims
- 0495US7034009B2Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)CHIRON CORP·Filed 2002·Granted Apr 25, 2006·49 cites·20 claims
- 0595US6818447B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorSIRNA THERAPEUTICS INC·Filed 2000·Granted Nov 16, 2004·49 cites·12 claims
- 0689US10538496B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·3 cites·5 claims
- 0789US10508088B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·3 cites·11 claims
- 0889US7700359B2Gene products differentially expressed in cancerous cellsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Apr 20, 2010·31 cites·9 claims
- 0987US11345672B2Methods using HDAC11 inhibitorsVALO HEALTH INC·Filed 2019·Granted May 31, 2022·2 cites·19 claims
- 1086US6521225B1AAV vectorsCHIRON CORP·Filed 1997·Granted Feb 18, 2003·57 cites·6 claims
- 1180US12479807B2Methods using HDAC11 inhibitorsVALO HEALTH INC·Filed 2022·Granted Nov 25, 2025·0 cites·2 claims
- 1280US5747338AMethod and construct for screening for inhibitors of transcriptional activationCHIRON CORP·Filed 1996·Granted May 5, 1998·68 cites·45 claims
- 1379US6964868B1Human genes and gene expression products IINUVELO INC·Filed 1999·Granted Nov 15, 2005·35 cites·9 claims
- 1478US5872218AHuman platelet-derived growth factor receptor extracellular domain antibodiesCOR THERAPEUTICS INC·Filed 1995·Granted Feb 16, 1999·39 cites·8 claims
- 1577US6043211AMethod for inhibiting the activity of a platelet-derived growth factor receptor binding proteinUNIV CALIFORNIA·Filed 1995·Granted Mar 28, 2000·31 cites·12 claims
- 1676US6110737AHuman platelet-derived growth factor receptor, type AUNIV CALIFORNIA·Filed 1994·Granted Aug 29, 2000·26 cites·10 claims
- 1775US5686572ADomains of extracellular region of human platelet derived growth factor receptor polypeptidesCOR THERAPEUTICS INC·Filed 1993·Granted Nov 11, 1997·35 cites·8 claims
- 1871US7105305B2Human platelet-derived growth factor receptorsUNIV CALIFORNIA·Filed 2001·Granted Sep 12, 2006·6 cites·6 claims
- 1971US6221646B1Materials and methods for simplified AAV productionCHIRON CORP·Filed 1998·Granted Apr 24, 2001·23 cites·17 claims
- 2067US2018127386A1Methods using hdac11 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2167US2009170197A1Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)SIRNA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2263US5891652AMethods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptidesUNIV CALIFORNIA·Filed 1995·Granted Apr 6, 1999·20 cites·15 claims
- 2356US6566075B1Methods for detecting human platelet-derived growth factor receptor agonists and antagonistsUNIV CALIFORNIA·Filed 2000·Granted May 20, 2003·0 cites·12 claims
- 2456US2007178527A1Human platelet-derived growth factor receptorsUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 2554US2012308569A1Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2012·Application pending·0 cites
- 2654US2003166284A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2002·Application pending·0 cites
- 2754US2002132336A1Replication-defective recombinant AAV virionsCHIRON CORP·Filed 2002·Application pending·0 cites
- 2853US7122373B1Human genes and gene expression products VNUVELO INC·Filed 1999·Granted Oct 17, 2006·14 cites·8 claims
- 2953US6475782B1Human platelet-derived growth factor receptorUNIV CALIFORNIA·Filed 1995·Granted Nov 5, 2002·5 cites·18 claims
- 3052US8221983B2Gene products differentially expressed in cancerous cellsCHAN VIVIEN W·Filed 2010·Granted Jul 17, 2012·0 cites·11 claims
- 3152US2014135384A1Endogenous retrovirus polypeptides linked to oncogenic transformationNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Application pending·0 cites
- 3252US2001051611A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2001·Application pending·0 cites
- 3351US2001034054A1Materials and methods for simplified AAV productionFiled 2001·Application pending·0 cites
- 3450US2003194406A1P-cadherin as a target for anti-cancer therapyCHIRON CORP·Filed 2002·Application pending·0 cites
- 3548US2004102389A1Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)RIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 3648US2007037147A1Endogenous retrovirus polypeptides linked to oncogenic transformationGARCIA PABLO·Filed 2002·Application pending·0 cites
- 3748US2003170656A1Method of screening for factors that modulate gene expressionCHIRON CORP·Filed 2002·Application pending·0 cites
- 3847US2003065156A1Novel human genes and gene expression products IFiled 2002·Application pending·0 cites
- 3947US2006039915A1P-cadherin as a target for anti-cancer therapyCHIRON CORP·Filed 2005·Application pending·0 cites
- 4045US2003215803A1Human genes and gene expression products isolated from human prostateFiled 2001·Application pending·0 cites
- 4144US2006275747A1Endogenous retrovirus up-regulated in prostate cancerHARDY STEPHEN F·Filed 2002·Application pending·0 cites
- 4244US2011020352A1Endogenous retroviruses up-regulated in prostate cancerNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 4342US2002076761A1Secreted human proteinsFiled 2001·Application pending·0 cites
- 4441US2004086913A1Human genes and gene expression products XVIFiled 2003·Application pending·0 cites
- 4540US6642022B1Platelet-derived growth factor receptorsUNIV CALIFORNIA·Filed 1995·Granted Nov 4, 2003·4 cites·50 claims
- 4639US6372438B1Human platelet-derived growth factor receptorsUNIV CALIFORNIA·Filed 1995·Granted Apr 16, 2002·4 cites·19 claims
- 4739US2007243176A1Human genes and gene expression productsESCOBEDO JAIME·Filed 2003·Application pending·0 cites
- 4838US2002076735A1Diagnostic and therapeutic methods using molecules differentially expressed in cancer cellsFiled 2001·Application pending·0 cites
- 4936US2003044783A1Human genes and gene expression productsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaime Escobedo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →